Market snapshot: August 7, 2026 close. This is independent research for education, not personal investment advice. It is not a recommendation to buy or sell; verify prices and filings before acting.
What changed since July 23#
The two pending decision points have now occurred: SpaceX reported its first public-company quarter on August 4, and the August 6 lock-up event arrived. That removes important uncertainty, but it does not make SPCX cheap.
Stance: Wait / cash-only accumulation only after a renewed valuation margin of safety — medium-high confidence. The July report’s $95–105 first-tranche framework was explicitly conditional on results and a stable post-unlock tape. At $133.11 on August 7, the shares are back above the prior $115 “wait” line, only about 1% below the $135 IPO price, and roughly 41% below the $225.64 high. The lock-up did not produce the feared immediate supply air-pocket; that is constructive for market plumbing, not proof that the long-duration valuation is conservative.
First results: operating validation, plus a much larger capital bill#
The reported quarter was meaningfully better operationally than the pre-earnings information set:
- Revenue was $7.814 billion, up 92% year over year; adjusted EBITDA was $3.538 billion, up 191%. The GAAP net loss nevertheless remained $541 million and operating loss was $143 million. The distinction matters: EBITDA is helpful, but is not cash earnings.
- Connectivity is the core proof point. Revenue was $4.291 billion (+66% year over year), operating income $1.656 billion (+79%), and Starlink subscribers reached 12.0 million, double a year earlier, while ARPU held at $66. The company also cited more than $6 billion of multi-year Starshield awards.
- Starship execution advanced. The company reported successful Flight 12 in May and Flight 13 in July, including V3 satellite deployment, an in-space Raptor relight, and an intact-heatshield splashdown view. This improves the operating thesis; it does not yet establish rapid reusability or commercial unit economics.
- AI is both the growth engine and the new risk concentration. AI revenue was $2.561 billion (+247% year over year), aided by $14.1 billion of cloud-services contracted sales, but AI operating loss was $1.257 billion and Q2 AI capex was $15.828 billion. Total company capex was $18.369 billion in the quarter, far above revenue. The announced $60 billion Cursor acquisition adds integration and capital-allocation risk.
The August 4 10-Q reinforces the same trade-off: six-month capex was $28.476 billion, versus $12.508 billion of revenue; June 30 cash and cash equivalents were $93.522 billion, largely bolstered by the IPO and financing. Long-term debt was $38.285 billion. That liquidity funds ambition, but it should not be mistaken for internally generated free cash flow.
Valuation, supply, and analyst signal#
At the August 7 close, the stock is no longer near the July accumulation ranges. Even using the much stronger Q2 revenue annualized, the equity value implied by the roughly 13.3 billion shares underlying the July market-cap estimate is about $1.8 trillion, or approximately 57x annualized Q2 revenue. Using the July report’s 2025 revenue base would be more demanding still. Neither calculation supports treating a good quarter as a valuation reset.
The August 6 unlock was a genuine catalyst resolution: shares became eligible to trade, yet the stock rallied sharply on August 7. That weakens the near-term “forced supply must dominate” argument, while leaving future insider selling, employee equity issuance, and high short interest as volatility risks. The 10-Q also disclosed employee-plan issuance and RSU grants, plus existing 10b5-1 arrangements; availability to sell is not the same as reported selling.
One notable revision was Bernstein’s reported increase to a $248 target after results. It is useful as a bullish scenario input, not a new consensus reality. The original research’s analyst range was extraordinarily wide ($63–$800), and the evidence now supports the same conclusion: revenue quality has improved, but the debate has shifted to capital intensity, AI contract durability, and whether Starship converts technical progress into economics.
Decision framework now#
The long-term company thesis is stronger after the quarter; the risk-adjusted entry thesis is not. I would require at least one of the following before becoming more constructive on the shares:
- A lower price that restores a clear margin of safety, with fundamentals intact.
- Evidence that AI capex converts into durable cash flow rather than only adjusted EBITDA and contracted-sales headlines.
- Repeated Starship performance demonstrating reusability and a credible path to lower launch cost.
Margin remains inappropriate. A stock capable of double-digit moves around earnings and a lock-up, with a large capex program and unresolved long-term valuation, is a poor candidate for borrowed-money exposure. Investors who choose to own it should use cash, modest sizing, and tranches; a correct business thesis does not protect a leveraged position from volatility or forced selling.